Insulin degludec and Recombinate recombinant
Determining the interaction of Insulin degludec and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin Degludec
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec-Recombivax
- Insulin degludec-Recombivax HB
- Insulin degludec-Recombivax HB Adult
- Insulin degludec-Recombivax HB Dialysis Formulation
- Insulin degludec-Recombivax HB Pediatric/Adolescent
- Insulin degludec-Recort Plus
- Recombinate recombinant-Insulin Degludec (U-100) Prefilled Pens
- Recombinate recombinant-Insulin Degludec (U-100) Vials
- Recombinate recombinant-Insulin Degludec (U-200) Prefilled Pens
- Recombinate recombinant-Insulin degludec and liraglutide
- Recombinate recombinant-Insulin degludec and liraglutide Subcutaneous
- Recombinate recombinant-Insulin degludec Subcutaneous